참고문헌
- Azmi L, Ojha SK, Rao CV (2015). Curcumin: boon for human beings. World J Pharmacy Pharmaceutical Sci, 4, 239-249.
- Bimonte S, Barbieri A, Palma G, et al (2015). Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer. BioMed Res Int, 2015.
-
Chaturvedi M, Sung B, Yadav V, Kannappan R, Aggarwal B (2011). NF-
${\kappa}B$ addiction and its role in cancer:'one size does not fit all'. Oncogene, 30, 1615-30. https://doi.org/10.1038/onc.2010.566 - Chen A, Xu J, Johnson A (2006). Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene, 25, 278-87. https://doi.org/10.1038/sj.onc.1209019
- Chung M-Y, Lim TG, Lee KW (2013). Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol, 19, 984. https://doi.org/10.3748/wjg.v19.i7.984
- Cildir G, Akincilar SC, Tergaonkar V (2013). Chronic adipose tissue inflammation: all immune cells on the stage. Trends Molecular Med, 19, 487-500. https://doi.org/10.1016/j.molmed.2013.05.001
- Das L and Vinayak M (2015). Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 Signalling and Modulation of Inflammation in Prevention of Cancer.
- Devassy JG, Nwachukwu ID, Jones PJ (2015). Curcumin and cancer: barriers to obtaining a health claim. Nutrition Rev, 64
- Divya CS, Pillai MR (2006). Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Molecular carcinogenesis, 45, 320-32. https://doi.org/10.1002/mc.20170
- Donipati P, Sreeramulu SH (2015). In vitro anticancer activity of Curcuma longa against human breast cancer. Cell Line Mcf, 7.
- Ferreira L, Arbab A, Jardim-Perassi B, et al (2015a). Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer. Anticancer Agents Med Chem, 15, 1285-96. https://doi.org/10.2174/1871520615666150520093644
- Ferreira LC, Arbab AS, Jardim-Perassi BV, (2015b). Abstract A02: Effect of curcumin on the tumor growth and angiogenesis of breast cancer. Cancer Res, 75, A02-A02.
-
Fiala M (2015). Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-
${\gamma}$ production: benefits of omega-3 with curcumin against cancer. Molecules, 20, 3020-6. https://doi.org/10.3390/molecules20023020 - Gao W, Chan JY, Wei WI, Wong TS (2012). Anti-cancer effects of curcumin on head and neck cancers. Anticancer Agents Med Chem, 12, 1110-6. https://doi.org/10.2174/187152012803529736
-
Gee VM, Wong FS, Ramachandran L, et al (2014). Identification of novel peroxisome proliferator-activated receptor-gamma (
$PPAR{\gamma}$ ). agonists using molecular modeling method. J Computer-Aided Molecular Design, 28, 1143-51. https://doi.org/10.1007/s10822-014-9791-6 - Gupta SC, Patchva S, Aggarwal BB (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J, 15, 195-218. https://doi.org/10.1208/s12248-012-9432-8
- Gupta SC, Prasad S, Kim JH, et al (2011). Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports, 28, 1937-55. https://doi.org/10.1039/c1np00051a
-
Huang T, Chen Z, Fang L (2013). Curcumin inhibits LPS-induced EMT through downregulation of NF-
${\kappa}B$ -Snail signaling in breast cancer cells. Oncol Reports, 29, 117-124. https://doi.org/10.3892/or.2012.2080 - Kapakos G, Youreva V, Srivastava AK (2012). Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells. Canadian J Physiol Pharmacol, 90, 1277-85. https://doi.org/10.1139/y2012-059
- Kolch W, Pitt A (2010). Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nature Reviews Cancer, 10, 618-29. https://doi.org/10.1038/nrc2900
- Lemmon MA, Schlessinger J (2010). Cell signaling by receptor tyrosine kinases. Cell, 141, 1117-34. https://doi.org/10.1016/j.cell.2010.06.011
-
Li F, Sethi G (2010). Targeting transcription factor NF-
${\kappa}B$ to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta -Reviews on Cancer, 1805, 167-80. https://doi.org/10.1016/j.bbcan.2010.01.002 - Li X, Chen S, Zhang B, et al (2012). In situ injectable nano-composite hydrogel composed of curcumin, N, O-carboxymethyl chitosan and oxidized alginate for wound healing application. Int J Pharmaceutics, 437, 110-9. https://doi.org/10.1016/j.ijpharm.2012.08.001
- Lopez-Bergami P, Lau E, Ronai Ze (2010). Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nature Review Cancer, 10, 65-76. https://doi.org/10.1038/nrc2681
- Low KC , Tergaonkar V (2013). Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochemical Sciences, 38, 426-34. https://doi.org/10.1016/j.tibs.2013.07.001
- Mishra A, Kumar R, Tyagi A, et al (2015). Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer. Ecancermedicalscience, 9.
- Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE (2014). Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials, 35, 3365-83. https://doi.org/10.1016/j.biomaterials.2013.12.090
- Niu T, Tian Y, Cai Q, Ren Q, Wei L (2015). Red light combined with blue light irradiation regulates proliferation and apoptosis in skin keratinocytes in combination with low concentrations of curcumin. PloS One, 10, 138754.
- Norris L, Karmokar A, Howells L, et al (2013). The role of cancer stem cells in the anti-carcinogenicity of curcumin. Mol Nutr Food Res, 57, 1630-7. https://doi.org/10.1002/mnfr.201300120
- Nunez-Sanchez MA, , Romo-Vaquero M, et al (2015). Dietary phenolics against colorectal cancer-From promising preclinical results to poor translation into clinical trials: Pitfalls and future needs. Mol Nutr Food Res, 59, 1274-91. https://doi.org/10.1002/mnfr.201400866
- Park W, Amin AR, Chen ZG, Shin DM (2013). New perspectives of curcumin in cancer prevention. Cancer Prev Res, 6, 387-400. https://doi.org/10.1158/1940-6207.CAPR-12-0410
- Roux PP, Blenis J (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Molecular Biol Reviews, 68, 320-44. https://doi.org/10.1128/MMBR.68.2.320-344.2004
- Sareen R, Jain N, Pandit V (2013). Curcumin: A boon to colonic diseases. Current Drug Targets, 14, 1210-8. https://doi.org/10.2174/13894501113149990168
- Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V (2012). Multifaceted link between cancer and inflammation. Bioscience Reports, 32, 1-15. https://doi.org/10.1042/BSR20100136
-
Sethi G, Sung B, Aggarwal BB (2008). Nuclear factor-
${\kappa}B$ activation: from bench to bedside. Exp Biol Med, 233, 21-31. https://doi.org/10.3181/0707-MR-196 -
Sethi G, Tergaonkar V (2009). Potential pharmacological control of the NF-
${\kappa}B$ pathway. Trends Pharmacological Sci, 30, 313-21. https://doi.org/10.1016/j.tips.2009.03.004 - Shanmugam MK, Kannaiyan R, Sethi G (2011). Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer, 63, 161-73. https://doi.org/10.1080/01635581.2011.523502
- Shanmugam MK, Rane G, Kanchi MM, et al (2015). The multifaceted role of curcumin in cancer prevention and treatment. Molecules, 20, 2728-69. https://doi.org/10.3390/molecules20022728
- Shanmugam MK, Sethi G (2013). Role of epigenetics in inflammation-associated diseases. Subcell Biochem, 61, 627-57.
- Sharma S, Kulkarni SK, Chopra K (2006). Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 33, 940-5. https://doi.org/10.1111/j.1440-1681.2006.04468.x
- Shehzad A, Lee J, Lee YS (2013). Curcumin in various cancers. Biofactors, 39, 56-68. https://doi.org/10.1002/biof.1068
- Siveen KS, Sikka S, Surana R, et al (2014). Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta - Reviews on Cancer, 1845, 136-54. https://doi.org/10.1016/j.bbcan.2013.12.005
- Soetikno V, Sari FR, Sukumaran V, et al (2013). Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. J Nutritional Biochem, 24, 796-802. https://doi.org/10.1016/j.jnutbio.2012.04.013
- Subramaniam A, Shanmugam MK, Perumal E, et al (2013). Potential role of signal transducer and activator of transcription (STAT). 3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta -Reviews on Cancer, 1835, 46-60. https://doi.org/10.1016/j.bbcan.2012.10.002
- Tyagi AK, Prasad S (2015). Targeting P53 Pathway by curcumin for cancer prevention and treatment. Cell Dev Biol, 4, 2.
- Wu J, Tang Q, Zhao S, et al (2014). Extracellular signalregulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin. Int J Oncol, 45, 95-103. https://doi.org/10.3892/ijo.2014.2420
- Xi Y, Gao H, Callaghan MU, et al (2015). Induction of BCL2-interacting killer, BIK, is mediated for anti-cancer activity of curcumin in human head and neck squamous cell carcinoma cells. J Cancer, 6, 327. https://doi.org/10.7150/jca.11185
- Yallapu MM, Nagesh PKB, Jaggi M, Chauhan SC (2015). Therapeutic applications of curcumin nanoformulations. AAPS J 17, 1341-56. https://doi.org/10.1208/s12248-015-9811-z
- Yao Q, Lin M, Wang Y, et al (2015). Curcumin induces the apoptosis of A549 cells via oxidative stress and MAPK signaling pathways. Int J Molecular Med, 36, 1118-26. https://doi.org/10.3892/ijmm.2015.2327
- Zlotogorski A, Dayan A, Dayan D, et al (2013). Nutraceuticals as new treatment approaches for oral cancer-I: curcumin. Oral Oncol, 49, 187-191. https://doi.org/10.1016/j.oraloncology.2012.09.015
- Zong H, Wang F, Fan Q-X, Wang L-X (2012). Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NFkappa B signaling pathways. Molecular Biology Reports, 39, 4803-8. https://doi.org/10.1007/s11033-011-1273-5